Imagine an investor waking up in early July to check their portfolio—expecting the usual sluggish dribble of listings after a slow first half. Instead, a wave of IPOs bursts through: NSDL, Anthem Biosciences, Tata Capital, BlueStone, Crizac, and m....
Read More